Sulfopyruvate
Star0
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Sulfopyruvate
- DrugBank Accession Number
- DB02156
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 168.125
Monoisotopic: 167.97285855 - Chemical Formula
- C3H4O6S
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as alpha-keto acids and derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the adjacent carbon.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Keto acids and derivatives
- Sub Class
- Alpha-keto acids and derivatives
- Direct Parent
- Alpha-keto acids and derivatives
- Alternative Parents
- Sulfonyls / Organosulfonic acids / Alpha-hydroxy ketones / Alkanesulfonic acids / Monocarboxylic acids and derivatives / Carboxylic acids / Organic oxides / Hydrocarbon derivatives
- Substituents
- Aliphatic acyclic compound / Alkanesulfonic acid / Alpha-hydroxy ketone / Alpha-keto acid / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Hydrocarbon derivative / Ketone / Monocarboxylic acid or derivatives
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- carboxyalkanesulfonic acid (CHEBI:16894)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 8D5GA7PEG6
- CAS number
- 98022-26-5
- InChI Key
- BUTHMSUEBYPMKJ-UHFFFAOYSA-N
- InChI
- InChI=1S/C3H4O6S/c4-2(3(5)6)1-10(7,8)9/h1H2,(H,5,6)(H,7,8,9)
- IUPAC Name
- 2-oxo-3-sulfopropanoic acid
- SMILES
- OC(=O)C(=O)CS(O)(=O)=O
References
- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0004045
- KEGG Compound
- C05528
- PubChem Compound
- 440717
- PubChem Substance
- 46508494
- ChemSpider
- 389590
- BindingDB
- 223201
- ChEBI
- 16894
- ZINC
- ZINC000004096823
- PDBe Ligand
- SPV
- PDB Entries
- 1m1b / 3dt7 / 3moe / 4gmm / 4gmz / 4gno / 4ox2 / 5fh4 / 5v9f
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 12.9 mg/mL ALOGPS logP -1.5 ALOGPS logP -0.74 Chemaxon logS -1.1 ALOGPS pKa (Strongest Acidic) -1.8 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 108.74 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 28.33 m3·mol-1 Chemaxon Polarizability 12.46 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.8413 Blood Brain Barrier + 0.9474 Caco-2 permeable - 0.6725 P-glycoprotein substrate Non-substrate 0.8662 P-glycoprotein inhibitor I Non-inhibitor 0.892 P-glycoprotein inhibitor II Non-inhibitor 0.9847 Renal organic cation transporter Non-inhibitor 0.9548 CYP450 2C9 substrate Non-substrate 0.892 CYP450 2D6 substrate Non-substrate 0.8395 CYP450 3A4 substrate Non-substrate 0.6723 CYP450 1A2 substrate Non-inhibitor 0.8786 CYP450 2C9 inhibitor Non-inhibitor 0.9001 CYP450 2D6 inhibitor Non-inhibitor 0.9221 CYP450 2C19 inhibitor Non-inhibitor 0.8922 CYP450 3A4 inhibitor Non-inhibitor 0.9895 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9919 Ames test Non AMES toxic 0.6236 Carcinogenicity Carcinogens 0.6995 Biodegradation Ready biodegradable 0.7118 Rat acute toxicity 1.9550 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9509 hERG inhibition (predictor II) Non-inhibitor 0.9249
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-006x-9300000000-8fb65d208d027ce47187 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-014i-0900000000-7856979a566df094c99a Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0uxu-6900000000-be588bd41d0882733b9c Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-9100000000-943482c6314a4f9eb011 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0006-9000000000-c6c3f0352f2684ae4069 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0006-9000000000-e1a75da7ff9f28d3bf0f Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-054o-9000000000-91e84d5918c0d1791bcc Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 130.2254834 predictedDarkChem Lite v0.1.0 [M-H]- 130.4820834 predictedDarkChem Lite v0.1.0 [M-H]- 124.95944 predictedDeepCCS 1.0 (2019) [M+H]+ 131.5286834 predictedDarkChem Lite v0.1.0 [M+H]+ 131.3737834 predictedDarkChem Lite v0.1.0 [M+H]+ 128.78893 predictedDeepCCS 1.0 (2019) [M+Na]+ 130.9266834 predictedDarkChem Lite v0.1.0 [M+Na]+ 130.9155834 predictedDarkChem Lite v0.1.0 [M+Na]+ 137.75188 predictedDeepCCS 1.0 (2019)
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52